Cargando…
Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers
Lassa fever afflicts tens of thousands of people in West Africa annually. The rapid progression of patients from febrile illness to fulminant syndrome and death provides incentive for development of clinical prognostic markers that can guide case management. The small molecule profile of serum from...
Autores principales: | Gale, Trevor V., Horton, Timothy M., Grant, Donald S., Garry, Robert F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619842/ https://www.ncbi.nlm.nih.gov/pubmed/28922385 http://dx.doi.org/10.1371/journal.pntd.0005943 |
Ejemplares similares
-
Elevated l-threonine is a biomarker for Lassa fever and Ebola
por: Gale, Trevor V., et al.
Publicado: (2020) -
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
por: Horton, Lucy E., et al.
Publicado: (2020) -
Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022) -
729. Lassa Fever Associated Hearing Loss
por: Ficenec, Samuel, et al.
Publicado: (2021) -
Data set on Lassa fever in post-conflict Sierra Leone
por: Shaffer, Jeffrey G., et al.
Publicado: (2019)